Treatment of Cutaneous Leiomyomas with Botulinum Toxin: Case Report and Review of Literature

    September 2021 in “ Dermatologic Therapy ”
    David Vega Díez, Ana Rodríguez‐Villa Lario, Marta González‐Cañete … Susana Medina
    Studysummary The researchers reported that intralesional botulinum toxin A effectively alleviated pain associated with cutaneous leiomyomas in a patient with hereditary leiomyomatosis and renal cell cancer syndrome, with repeated treatments every three months maintaining pain relief over 1.5 years.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 1

    1. The Non-Neuronal and Nonmuscular Effects of Botulinum Toxin: An Opportunity for a Deadly Molecule to Treat Disease in the Skin and Beyond British Journal of Dermatology · 2017